Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Mells

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Translational Autoimmunity|February 8, 2021
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparisonLorenzo Montali, Andrea Gragnano, Massimo Miglioretti, et al.
Journal of Hepatology|May 25, 2020
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registryAndrew M Moon, Gwilym J Webb, Costica Aloman, et al.
Ebiomedicine|May 24, 2022
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort studyDavid E J Jones, Aaron Wetten, Ben Barron-Millar, et al.
Gut Microbes|May 16, 2023
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitisLaura Martinez-Gili, Alexandros Pechlivanis, Julie A K McDonald, et al.
Hepatology (Baltimore, Md.)|June 15, 2021
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary CholangitisBen Barron-Millar, Laura Ogle, George Mells, et al.
Hepatology (Baltimore, Md.)|December 4, 2024
Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study designM Alan Brookhart, Tracy J Mayne, Charles Coombs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2022
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary CholangitisNadir Abbas, Emma L Culver, Douglas Thorburn, et al.
The American Journal of Gastroenterology|December 2, 2024
Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External ControlsKris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
Hepatology (Baltimore, Md.)|March 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder, et al.
The American Journal of Gastroenterology|August 14, 2024
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External ControlsKris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Translational Autoimmunity|February 8, 2021
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparisonLorenzo Montali, Andrea Gragnano, Massimo Miglioretti, et al.
Journal of Hepatology|May 25, 2020
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registryAndrew M Moon, Gwilym J Webb, Costica Aloman, et al.
Ebiomedicine|May 24, 2022
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort studyDavid E J Jones, Aaron Wetten, Ben Barron-Millar, et al.
Gut Microbes|May 16, 2023
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitisLaura Martinez-Gili, Alexandros Pechlivanis, Julie A K McDonald, et al.
Hepatology (Baltimore, Md.)|June 15, 2021
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary CholangitisBen Barron-Millar, Laura Ogle, George Mells, et al.
Hepatology (Baltimore, Md.)|December 4, 2024
Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study designM Alan Brookhart, Tracy J Mayne, Charles Coombs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2022
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary CholangitisNadir Abbas, Emma L Culver, Douglas Thorburn, et al.
The American Journal of Gastroenterology|December 2, 2024
Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External ControlsKris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
Hepatology (Baltimore, Md.)|March 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder, et al.
The American Journal of Gastroenterology|August 14, 2024
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External ControlsKris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
Pageof 4